Findings
COLD
In this open-label randomized clinical trial of 72 liver transplant recipients allocated to either static cold storage (standard of care) with an add-on combined drug approach delivered to the preimplantation liver and recipient or to standard of care only, peak aspartate aminotransferase serum levels and other functional, laboratory, and survival outcomes were similar between groups.